Literature DB >> 11425771

Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy.

P Turrini1, D Corrado, C Basso, A Nava, B Bauce, G Thiene.   

Abstract

BACKGROUND: We retrospectively investigated the value of clinical and ECG findings as well as QT-QRS dispersion in predicting the risk of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS AND
RESULTS: Duration and interlead variability of the QT interval and QRS complex were measured manually from standard ECGs in 20 sudden death victims with ARVC diagnosed at autopsy (group I), in 20 living ARVC patients with sustained ventricular tachycardia (group II), in 20 living ARVC patients with </=3 consecutive premature ventricular beats (group III), and in 20 control subjects (group IV). QT and QRS dispersions were greater in group I (77.5+/-10.6 ms for QT and 45.7+/-8.1 ms for QRS) compared with group II (64.5+/-13.9 ms for QT [P=0.001] and 33.5+/-8.7 ms for QRS [P=0.0004]) and in group II compared with group III (48+/-8.9 ms for QT [P<0.0001] and 28+/-5.2 ms for QRS [P<0.0001]) and group IV (33.5+/-4.8 ms for QT [P<0.0001] and 18.5+/-3.6 ms for QRS [P<0.0001]). Negative T wave beyond V(1) and syncope were statistically more frequent in group I (P=0.02 and P=0.007, respectively). On multivariate analysis, QRS dispersion remained an independent predictor of sudden death (P<0.0001), followed by syncope (P=0.09). In assessing risk of sudden death, QRS dispersion >/=40 ms had a sensitivity and specificity of 90% and 77%, respectively; QT dispersion >65 ms, 85% and 75%, respectively; negative T wave beyond V(1), 85% and 42%, respectively; and syncope, 40% and 90%, respectively.
CONCLUSIONS: QRS dispersion (>/=40 ms) was the strongest independent predictor of sudden death in ARVC. Syncope, QT dispersion >65 ms, and negative T wave beyond V(1) refined arrhythmic risk stratification in these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11425771     DOI: 10.1161/01.cir.103.25.3075

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

Review 1.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

Review 2.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.

Authors:  Gianfranco Buja; N A Mark Estes; Thomas Wichter; Domenico Corrado; Frank Marcus; Gaetano Thiene
Journal:  Prog Cardiovasc Dis       Date:  2008 Jan-Feb       Impact factor: 8.194

Review 3.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.

Authors:  Thomas Herren; Philipp A Gerber; Firat Duru
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

Review 4.  Genetics of sudden cardiac death.

Authors:  Alon Barsheshet; Andrew Brenyo; Arthur J Moss; Ilan Goldenberg
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

5.  Risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  M Silvano; D Corrado; J Köbe; G Mönnig; C Basso; G Thiene; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-10-11

6.  Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Alexandros Protonotarios; Aris Anastasakis; Demosthenes B Panagiotakos; Loizos Antoniades; Petros Syrris; Apostolos Vouliotis; Christodoulos Stefanadis; Adalena Tsatsopoulou; William J McKenna; Nikos Protonotarios
Journal:  Europace       Date:  2015-03-29       Impact factor: 5.214

7.  Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited.

Authors:  Stefan Peters; Martina Trümmel
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

8.  Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.

Authors:  K Lemola; C Brunckhorst; U Helfenstein; E Oechslin; R Jenni; F Duru
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

Review 9.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 10.  12-lead electrocardiogram features of arrhythmic risk: A focus on early repolarization.

Authors:  Caterina Rizzo; Francesco Monitillo; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.